Innospec Inc. (NASDAQ:IOSP – Get Free Report) Director David Landless sold 594 shares of Innospec stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the transaction, the director owned 7,632 shares in the company, valued at approximately $584,305.92. This represents a 7.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Innospec Stock Performance
IOSP stock traded down $0.67 during trading on Tuesday, hitting $76.37. 219,803 shares of the company traded hands, compared to its average volume of 214,515. The company has a 50-day moving average of $81.07 and a 200-day moving average of $79.08. Innospec Inc. has a 1 year low of $70.10 and a 1 year high of $102.25. The firm has a market capitalization of $1.89 billion, a PE ratio of 16.32, a P/E/G ratio of 2.03 and a beta of 0.90.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, February 17th. The specialty chemicals company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.24. Innospec had a return on equity of 10.18% and a net margin of 6.56%.The firm had revenue of $455.60 million during the quarter, compared to the consensus estimate of $460.87 million. During the same quarter in the previous year, the company posted $1.41 earnings per share. The business’s revenue was down 2.4% on a year-over-year basis. Sell-side analysts expect that Innospec Inc. will post 6.18 EPS for the current year.
Institutional Investors Weigh In On Innospec
Analysts Set New Price Targets
A number of brokerages have issued reports on IOSP. Weiss Ratings raised shares of Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, February 19th. Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. Finally, Zacks Research downgraded Innospec from a “hold” rating to a “strong sell” rating in a report on Thursday, February 19th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Innospec currently has a consensus rating of “Reduce”.
View Our Latest Report on IOSP
Innospec Company Profile
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
Featured Stories
- Five stocks we like better than Innospec
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
